Evaluating the Impact of the Bridge Clinic in Patients With Opioid Use Disorder
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 335
- 试验地点
- 1
- 主要终点
- Hospital Length of Stay
研究概览
简要总结
This study aims to determine whether referral to the Bridge Clinic reduces overall index hospital length of stay when compared to direct referral to a long-term outpatient addiction provider for patients with active opioid use disorder (OUD) being considered for medications-for-addiction treatment (MAT).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inpatients at VUH with active OUD being considered for MAT.
- •Patient accepting a transitional prescription for buprenorphine-naloxone or IM naltrexone whose outpatient plans are not fixed
排除标准
- •Deemed ineligible for referral to outpatient Bridge Clinic by the Addiction Consult Team (examples include but are not limited to patients with severe, active co-occurring psychiatric disorders requiring a higher level of psychiatric care or patients for whom methadone maintenance is deemed the best choice of MAT).
- •Patients previously randomized in this study.
研究组 & 干预措施
Usual Care
Participants randomized to this arm will receive care as usual.
干预措施: Usual Care (Other)
Bridge Clinic
Participants randomized to this arm will be referred to the Bridge Clinic to facilitate identification and referral to an outpatient provider for addiction treatment.
干预措施: Bridge Clinic (Other)
结局指标
主要结局
Hospital Length of Stay
时间窗: approximately 3 to 42 days
Overall index hospital length of stay measured in days
次要结局
- Number of MAT Prescriptions Filled by Participant(16 weeks post-randomization)
- Number of Participants With Successful Care Linkage(16 weeks post-randomization)
- Hospital and ED Free Days(16 weeks post-randomization)
- Readmissions and Emergency Department (ED) Visits(16 weeks post-randomization)
- Overdose(16 weeks post-randomization)
- Opioid Use Within 30 Days(30 days)
- Quality of Life - Schwartz Outcome Scale-10 (SOS10).(16 weeks post-randomization)
- Combined Cost of Index Admission and Subsequent Admissions During the Study Period(16 weeks post-randomization)
- Mortality(16 weeks post-randomization)
- Recurrent Opioid Use(16 weeks post-randomization)
研究者
David Marcovitz
Assistant Professor of Psychiatry, MD
Vanderbilt University Medical Center